Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective

被引:32
作者
Gupta, Sneha [1 ]
Biswas, Arijit [1 ]
Akhter, Mohammad Suhail [1 ]
Krettler, Christoph [2 ]
Reinhart, Christoph [2 ]
Dodt, Johannes [3 ]
Reuter, Andreas [3 ]
Philippou, Helen [4 ]
Ivaskevicius, Vytautas [1 ]
Oldenburg, Johannes [1 ]
机构
[1] Univ Clin Bonn, Inst Expt Haematol & Transfus Med, D-53127 Bonn, Germany
[2] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60439 Frankfurt, Germany
[3] Paul Ehrlich Inst, D-63225 Langen, Germany
[4] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
关键词
CALCIUM-BINDING SITE; AMINO-ACID-SEQUENCE; CROSS-LINKING; B-SUBUNIT; TRANSGLUTAMINASE; PEPTIDE; MUTATIONS; IDENTIFICATION; INHIBITORS; ENZYMES;
D O I
10.1038/srep30105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The activation and regulation of coagulation Factor XIII (FXIII) protein has been the subject of active research for the past three decades. Although discrete evidence exists on various aspects of FXIII activation and regulation a combinatorial structure/functional view in this regard is lacking. In this study, we present results of a structure/function study of the functional chain of events for FXIII. Our study shows how subtle chronological submolecular changes within calcium binding sites can bring about the detailed transformation of the zymogenic FXIII to its activated form especially in the context of FXIIIA and FXIIIB subunit interactions. We demonstrate what aspects of FXIII are important for the stabilization (first calcium binding site) of its zymogenic form and the possible modes of deactivation (thrombin mediated secondary cleavage) of the activated form. Our study for the first time provides a structural outlook of the FXIIIA(2)B(2) heterotetramer assembly, its association and dissociation. The FXIIIB subunits regulatory role in the overall process has also been elaborated upon. In summary, this study provides detailed structural insight into the mechanisms of FXIII activation and regulation that can be used as a template for the development of future highly specific therapeutic inhibitors targeting FXIII in pathological conditions like thrombosis.
引用
收藏
页数:16
相关论文
共 69 条
[1]   Protein crosslinking in assembly and remodelling of extracellular matrices: The role of transglutaminases [J].
Aeschlimann, D ;
Thomazy, V .
CONNECTIVE TISSUE RESEARCH, 2000, 41 (01) :1-+
[2]   Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot [J].
Bagoly, Zsuzsa ;
Haramura, Gizella ;
Muszbek, Laszlo .
THROMBOSIS AND HAEMOSTASIS, 2007, 98 (02) :359-367
[3]   Electrostatics of nanosystems: Application to microtubules and the ribosome [J].
Baker, NA ;
Sept, D ;
Joseph, S ;
Holst, MJ ;
McCammon, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10037-10041
[4]  
Baker S B, 2002, Crit Care Resusc, V4, P301
[5]   Coagulation factor XIII deficiency [J].
Biswas, A. ;
Ivaskevicius, V. ;
Thomas, A. ;
Oldenburg, J. .
HAMOSTASEOLOGIE, 2014, 34 (02) :160-166
[6]   Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function [J].
Biswas, Arijit ;
Ivaskevicius, Vytautas ;
Thomas, Anne ;
Varvenne, Michael ;
Brand, Brigitte ;
Rott, Hannelore ;
Haussels, Iris ;
Ruehl, Heiko ;
Scholz, Ute ;
Klamroth, Robert ;
Oldenburg, Johannes .
ANNALS OF HEMATOLOGY, 2014, 93 (10) :1665-1676
[7]   In Vitro Secretion Deficits are Common Among Human Coagulation Factor XIII Subunit B Missense Mutants: Correlations with Patient Phenotypes and Molecular Models [J].
Biswas, Arijit ;
Thomas, Anne ;
Bevans, Carville G. ;
Ivaskevicius, Vytautas ;
Oldenburg, Johannes .
HUMAN MUTATION, 2013, 34 (11) :1490-1500
[8]   An update of the mutation profile of Factor 13 A and B genes [J].
Biswas, Arijit ;
Ivaskevicius, Vytautas ;
Seitz, Rainer ;
Thomas, Anne ;
Oldenburg, Johannes .
BLOOD REVIEWS, 2011, 25 (05) :193-204
[9]  
CARRELL NA, 1989, J BIOL CHEM, V264, P551
[10]   The Amber biomolecular simulation programs [J].
Case, DA ;
Cheatham, TE ;
Darden, T ;
Gohlke, H ;
Luo, R ;
Merz, KM ;
Onufriev, A ;
Simmerling, C ;
Wang, B ;
Woods, RJ .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2005, 26 (16) :1668-1688